On-Demand Webinar

Formulate Faster: A Purpose-Built Toolkit for Bioequivalence (Phoenix IVIVC Toolkit)

This webinar introduces the Phoenix IVIVC Toolkit, showing how to perform BE analysis and build…

Certara2026 年 2 月 27 日

Webinar

Maximizing the Impact of Antibody–Drug Conjugates (ADCs): Model-Informed Labeling, Expansion, and Market Access

Danielle Pillsbury2026 年 2 月 23 日

On-Demand Webinar

Alternative parameters in NCA using Phoenix WinNonlin

Learn how to enhance formulation evaluation using Phoenix tools to calculate advanced PK parameters beyond…

Certara2026 年 2 月 23 日

Blog

FAQs: The ICH M15 guideline and what it means for model-informed drug development

Learn what the ICH M15 guideline means for Model-Informed Drug Development, regulatory credibility, harmonization, and…

Certara2026 年 2 月 18 日

Guide

Guided by Evidence: Implementing the ICH M15 Guideline for Model-Informed Drug Development (MIDD)

Prepare for ICH M15 guideline: Learn how to assess model credibility, align terminology, and strengthen…

Certara2026 年 2 月 13 日

On-Demand Webinar

The “Easy Button” for PK/PD TFLs and Reports (TFL Studio & AI PK Reports)

Watch to see how Phoenix TFL Studio and AI PK Reports automate the final stages…

Certara2026 年 2 月 12 日

Blog

Pediatric drug development: From “wild west” to model-informed confidence

Model-informed drug development and precision dosing are transforming pediatric programs, from regulatory planning to Bayesian…

Certara2026 年 2 月 11 日

Live Events

Phoenix Roadshow 2026 – Florence

Certara2026 年 2 月 2 日

Publication

Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants

This study, published in Clinical Pharmacology & Therapeutics (CPT), shows how population pharmacokinetic modeling supports…

Certara2026 年 2 月 2 日

On-Demand Webinar

Modeling Population PK with Power, Speed, and Ease-of-Use (Phoenix® NLME & Pirana®)

Discover population PK modeling made faster and easier with Phoenix NLME and Pirana in this…

Certara2026 年 1 月 30 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

Modeling and Simulation – PK/PD

Formulate Faster: A Purpose-Built Toolkit for Bioequivalence (Phoenix IVIVC Toolkit)

Maximizing the Impact of Antibody–Drug Conjugates (ADCs): Model-Informed Labeling, Expansion, and Market Access

Alternative parameters in NCA using Phoenix WinNonlin

FAQs: The ICH M15 guideline and what it means for model-informed drug development

Guided by Evidence: Implementing the ICH M15 Guideline for Model-Informed Drug Development (MIDD)

The “Easy Button” for PK/PD TFLs and Reports (TFL Studio & AI PK Reports)

Pediatric drug development: From “wild west” to model-informed confidence

Phoenix Roadshow 2026 – Florence

Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants

Modeling Population PK with Power, Speed, and Ease-of-Use (Phoenix® NLME & Pirana®)

订阅时事通讯

快捷链接

解决方案

联系我们